Question follow-through · 9410
Coronavirus: Vaccination
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 October 2024 to Question 8098 on Coronavirus: Vaccination, whether any line extensions to Covid-19 vaccinations have been authorised to tackle reported adverse side eff
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 16 Oct 2024
- Target answer date
- 21 Oct 2024
- Answer
- 21 Oct 2024 · 5 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Vaccine Damage Payment Scheme · 23 Oct 2024
- Coronavirus: Vaccination · 23 Oct 2024
- Coronavirus: Vaccination · 23 Oct 2024
- Coronavirus: Vaccination · 23 Oct 2024
- Coronavirus: Vaccination · 23 Oct 2024
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
16 Oct 2024
Question tabled
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 October 2024 to Question 8098 on Coronavirus: Vaccination, whether any line extensions to Covid-19 vaccinations have been authorised to tackle reported adverse side eff
21 Oct 2024
Target answer date
Date supplied by the official written-questions record.
21 Oct 2024
Answer published
The most common side effects observed with COVID-19 vaccines are pain and swelling at the injection site, tiredness, headaches, muscle and joint pain, chills, fever, and diarrhoea. These side effects are similar to those seen with other vaccines and are u...
Official data retrieved 27 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Vaccine Damage Payment Scheme
23 Oct 2024 · To ask the Secretary of State for Health and Social Care, if he will meet with Professor Adam Finn to discuss the Vaccine Damage Payment Scheme (a) 60% threshold, (b) levels of payments in the context of levels of inflation and (c) the potential impact of
Coronavirus: Vaccination
23 Oct 2024 · To ask the Secretary of State for Health and Social Care, when the use of the AstraZeneca Covid-19 vaccine Vaxrevia ended in the UK; and for what reason that vaccine is no longer available.
Coronavirus: Vaccination
23 Oct 2024 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 October 2024 to Question 9409 on Vaccine Damage Payment Scheme, if he will launch a consultation with Cabinet colleagues on the potential merits of bringing forward leg
Coronavirus: Vaccination
23 Oct 2024 · To ask the Secretary of State for Health and Social Care, on what date he met representatives of those (a) injured and (b) bereaved as a result of Covid-19 vaccine damage; and what steps he has taken as a result of that meeting.
Coronavirus: Vaccination
23 Oct 2024 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 October 2024 to Question 9410 on Coronavirus: Vaccination, whether any line extensions to covid-19 vaccinations have been authorised to tackle reported adverse side eff
Thyroid Diseases: Prescriptions
13 Nov 2024 · To ask the Secretary of State for Health and Social Care, for what reason there are different rules for exemptions from NHS prescription charges for people with (a) hypothyroidism and (b) hyperthyroidism.
Coronavirus: Vaccination
13 Nov 2024 · To ask the Secretary of State for Health and Social Care, what support is available from the NHS for people requiring neurological rehabilitation following a covid-19 vaccination.
Coronavirus: Vaccination
27 Nov 2024 · To ask the Secretary of State for Health and Social Care, whether any of the vials of (a) Pfizer and (b) Moderna covid-19 vaccines supplied to patients in the United Kingdom contained (i) variable and (ii) excessive levels of residual plasmid DNA.
Vaccine Damage Payment Scheme: Coronavirus
27 Nov 2024 · To ask the Secretary of State for Health and Social Care, how many claims to the Vaccine Damage Payment Scheme on Covid-19 vaccinations have been (a) received, (b) successful, (c) unsuccessful as a result of the claim not meeting the 60 per cent disabilit
Continuing Care: Dorset
10 Dec 2024 · To ask the Secretary of State for Health and Social Care, whether there is a maximum time within which applications for NHS Continuing Healthcare funding to NHS Dorset must be actioned; and whether redress is available to applicants whose applications hav
Smoking: Young People
11 Dec 2024 · To ask the Secretary of State for Health and Social Care, what assessment of the probability of an increase in youth smoking rates of illegal tobacco products as a result of the implementation of a generational ban on tobacco sales.
Smoking: Young People
11 Dec 2024 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the probability of young people switching from vaping to smoking tobacco products as a result of the implementation of a generational ban on tobacco sales.